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Introduction: Dyspnea is common among lung cancer patients. As
most studies of dyspnea have reviewed patients with active cancer or
immediately after treatment, its prevalence during the longer-term
period once treatment has been completed is not well characterized.
This study quantifies the prevalence of dyspnea among lung cancer
survivors and identifies potential correlates that may be amenable to
intervention.
Methods: Cross-sectional survey of 342 patients with disease-free,
stage I, non-small cell lung cancer, assessed 1 to 6 years after
surgical resection. Dyspnea was quantified using the Baseline Dys-
pnea Index. Any moderate/strenuous physical activity was measured
using the Godin Leisure-Time Exercise Questionnaire. Mood disor-
der symptoms were assessed using the Hospital Anxiety and De-
pression Scale. Multiple regression analyses were used to examine
demographic, medical, and health-related correlates of dyspnea.
Results: Mean age was 68.9 years. Average predicted preoperative
forced expiratory volume in 1 second was 89.0%. Current dyspnea,
defined by a Baseline Dyspnea Index score of 9 or less, existed
among 205 (60%) individuals. For 133 (65%) of these patients,
dyspnea was absent preoperatively. Multivariate correlates of cur-
rent dyspnea included preoperative dyspnea (odds ratio [OR] 
5.31), preoperative diffusing capacity (OR  0.98), lack of moder-
ate/strenuous physical activity (OR  0.41), and the presence of
clinically significant depression symptoms (OR  4.10).
Conclusions: Dyspnea is common 1 to 6 years after lung cancer
resection, and is associated with the presence of preoperative dys-
pnea, reduced diffusing capacity, clinically significant depression
symptoms, and lack of physical activity. Further research is needed
to test whether strategies that identify and treat patients with these
conditions attenuate dyspnea among lung cancer survivors.
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An estimated 215,000 individuals were diagnosed with lungcancer in the United States during 2008.1 Although lung
cancer remains the leading cause of cancer mortality in men and
women, the relatively high 5-year survival rate for stage I
disease, now exceeding 55%,2 and the near doubling of the
5-year survival rate since the 1960s, provides some room for
optimism. Even with the small 15 to 20% expected cure rate for
all stages, there are about 40,000 newly diagnosed individuals
annually who may become long-term survivors.
Understanding the prevalence and severity of pulmo-
nary comorbidities is essential for targeting appropriate care
to this growing number of survivors. To date, most studies
have focused on the short-term (i.e., 1 year) morbidity
associated with surgery, radiation, and chemotherapy.3–6 Not
surprisingly, these studies have shown pulmonary symptoms
to be highly prevalent. One study found that the most com-
mon symptoms 1 to 4 months after curative surgery were
fatigue (57%) and dyspnea (49%).6 In another study, Dales et
al.7 reported moderate to severe dyspnea among 31% of
patients within 3 months of lung cancer resection.
Relatively little is known about the long-term preva-
lence, severity, and impact of respiratory symptoms. In a
single study regarding dyspnea, Sarna et al.8 examined pul-
monary disability 5 or more years after curative surgery.
Among 142 patients, whose median time from surgery was
10 years, 63% reported chronic dyspnea, and 15% were so
dyspneic that they could not leave their homes or dress
themselves. These findings not only support the findings of
other investigators regarding the high prevalence of dyspnea,
but imply it can persist for a prolonged period of time.
This study builds on this earlier work implicating dyspnea
as a chronic problem after lung-cancer surgery. The goals of this
study are 2-fold: (1) to describe the prevalence and severity of
current dyspnea among lung cancer survivors and (2) to identify
specific correlates associated with dyspnea that may help clini-
cians target post-treatment rehabilitation strategies. In contrast to
earlier work, this study includes a larger sample size and incor-
porates measures of depression and anxiety. Although dyspnea
has been associated with reduced health-related quality of life
among lung cancer survivors,8 there is a lack of information
regarding its potential association with mood disorders in this
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population. Furthermore, the time period encompassed by this
study, 1 to 6 years after resection, has not been extensively
studied and is a critical period for the delivery of post-treatment
interventions.
MATERIALS AND METHODS
Patient Selection
A random patient sample, stratified by time since diag-
nosis, was extracted from an institutional database containing
demographic and medical information of all patients under-
going surgical resection for non-small cell lung cancer
(NSCLC) at a comprehensive cancer center in New York
City. At the time of patient accrual, the standard treatment for
stage I NSCLC was surgical resection.
Participants were eligible if they met the following
criteria: (1) previous diagnosis of stage IA or IB NSCLC, (2)
had undergone surgical resection with curative intent, (3)
were between one and 6 years post-treatment, (4) had no
evidence of lung cancer at time of recruitment, (5) could be
reached by phone, (6) had no psychiatric or cognitive impair-
ment judged to interfere with participation (as defined by a
score of 4 on the Brief Six-Item Screener),9 and (7) could
give informed consent.
Procedure
Permission to contact survivors was obtained from each
of their thoracic surgeons, who cosigned introductory letters
explaining the nature of the study. Survivors received these
letters along with consent forms and research authorizations.
Within 2 weeks of sending the letters, a research assistant
phoned survivors to determine eligibility and interest in the
study. Interested participants provided verbal consent and
could either complete a phone survey or a mailed paper and
pencil survey. The survey required 45 to 60 minutes for
completion and included several questions beyond the scope
of this study. All participants were offered print educational
resources for psychosocial and rehabilitation services. The
study was approved by the Institutional Review Board.
Measures
Primary Outcome
Current dyspnea was measured using a self-report ver-
sion of the Baseline Dyspnea Index (BDI),10 a scale that
assesses dyspnea severity along three dimensions: (1) func-
tional impairment in tasks of daily living caused by dyspnea,
(2) intensity of everyday tasks a person can complete without
experiencing dyspnea, and (3) general effort a person can
expend before experiencing dyspnea. Dyspnea is graded on a
five-point (0–4) scale from “very severe” to “no impairment”
for each dimension. An additional qualifying item was added
to indicate inability to function due to reasons other than
dyspnea. Responses across the items are summed to achieve
a final value of zero through 12 with lower scores indicating
more severe dyspnea.
The BDI has been well validated in the literature11 and
used to assess dyspnea in patients with emphysema undergo-
ing lung volume reduction surgery,12 outpatient pleurodesis
of malignant pleural effusions,13 and to evaluate the outcomes
of such medical interventions as bronchodilator therapy14 and
exercise training.15 Current dyspnea was defined as a score of
9 or less. This cutoff has been used in previous research16 and
ensures that those categorized as having dyspnea experienced
symptoms that were at least mild in severity (i.e., an average
of 3 or less for each dimension). Examples in this cohort of
the limitation experienced by patients with BDI scores of 9
include a 64-year-old woman who experienced breathlessness
carrying heavy objects, and a 74-year-old woman who expe-
rienced dyspnea walking up a hill.
Demographics
Demographic variables collected via self-report were
age, sex, marital/partnership status, employment status, race/
ethnicity, and education ( high school diploma, at least
some college).
Medical and Health-Related Correlates
Data regarding potential medical and health-related
correlates of current dyspnea were prospectively identified by
the investigators and obtained from the medical record. These
included elapsed time since surgery, type of surgery (wedge
resection, segmentectomy, lobectomy, bilobectomy, or pneu-
monectomy), preoperative dyspnea (yes/no), preoperative
forced expiratory volume in 1 second (FEV1) expressed in
percent predicted, preoperative diffusing capacity for carbon
monoxide expressed in percent predicted, use of video-as-
sisted thoracoscopic surgery only (yes/no), and preoperative
body mass index (BMI). Pulmonary function tests are ob-
tained for all patients as part of routine clinical care per
recommendations of the American College of Chest Physi-
cians.17 Therefore, the presence or absence of FEV1 and/or
diffusing capacity measurements in the medical record did
not influence patient selection. Also recorded was the pres-
ence of preoperative cardiac or pulmonary disease (yes/no).
Cardiac disease was defined as atrial fibrillation, angina,
previous coronary artery bypass graft surgery, hypertension,
previous myocardial infarction, previous percutaneous trans-
luminal coronary angioplasty, or valvular heart disease. Lung
disease was defined as previous asthma, chronic obstructive
pulmonary disease (COPD), interstitial lung disease, or tu-
berculosis (Table 2). Lung cancer was not considered a lung
disease for the purpose of this analysis, as it was an inclusion
criterion for all patients.
The presence or absence of preoperative dyspnea was
determined dichotomously by patient self-report on standard
intake forms used by the Department of Thoracic Surgery as
part of routine clinical practice. Typically, self-report occurs
within 1 month of surgery. Preoperative BMI was calculated
from the height and weight measured at the preoperative
anesthesia visit.
Patients also reported current smoking status, physical
activity, and the presence of depression and anxiety symptoms.
Given recent Centers for Disease Control recommendations for
older adults to get at least some moderate/strenuous physical
activity,18 this variable was defined dichotomously as the
presence or absence of any moderate or strenuous activity by
self report using the Godin Leisure-Time Exercise Question-
naire.19 As respiratory symptoms have been associated with
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reduced health-related quality of life,8 we assessed the pres-
ence of clinically significant mood disorder symptoms using
a standard cutoff of eight or more on each subscale of the
Hospital Anxiety and Depression Scale (HADS).20
Statistical Plan
Variables listed earlier, prospectively identified as
likely associated with current dyspnea (BDI 9), were ex-
amined via bivariate Pearson correlations. These were age,
sex, employment status, education, elapsed time since surgi-
cal resection, type of surgery, preoperative dyspnea, preop-
erative FEV1, preoperative diffusing capacity, use of video-
assisted thoracoscopic surgery only surgery, preoperative
BMI, preoperative cardiac disease, preoperative lung disease
excluding lung cancer, any history of tobacco use, any mod-
erate/strenuous physical activity, clinically significant depres-
sion symptoms (HADS8), and clinically significant anxiety
symptoms (HADS 8). Multiple logistic regression was
employed to examine the relative influence among the set of
variables that had bivariate correlations with dyspnea at p 
0.05. Analyses were conducted using SAS v9.1, and a p value
of 0.05 was used to determine statistical significance.
RESULTS
A total of 1,017 patients with NSCLC were identified
as potentially eligible from the institutional database. Of
these, 507 did not meet eligibility criteria. The most common
reasons for exclusion were current malignancy (n  144
patients), more than 6 years since surgical resection (n 
95), deceased (n  57), pathologic stage II-IV disease (n 
55), and the inability to speak English (n  47). Among
the 556 potentially eligible patients, 151 declined to partici-
pate. Reasons cited for declining participation included lack
of interest (n  23), wishing to avoid discussing cancer (n 
20) and feeling too poorly to participate (n  10). Cumula-
tively, 359 eligible patients provided informed consent (65%
participation rate) and 342 provided analyzable dyspnea data.
Recruitment and data collection were conducted from Sep-
tember 2005 through July 2007. There were no statistically
significant (p  0.05) differences between those who com-
pleted the survey and those who declined participation with
regard to mean age, sex, time since resection, pathologic
stage, preoperative pulmonary function, type of resection,
length of hospital stay, and number of surgical complications.
However, individuals who completed the study were less
likely to have reported preoperative dyspnea (21.1%) than
those who declined participation (29.8%, p  0.02).
Tables 1 and 2 show demographic and medical char-
acteristics respectively. The sample was mostly female
(63.5%), non-Hispanic White (93.0%), married or living with
a partner (62.0%), and well educated (68.0% had some
college education). The mean age was 68.9 years and the
mean time since treatment completion was 3.5 years. Most
(75.6%) patients had undergone lobectomy. In addition, 18
patients had received adjuvant chemotherapy, two of whom
also received radiation. Nearly 60% percent of the sample
was overweight or obese prior to surgery. Former smokers
comprised 78.4% of the sample; 5.5% continued to smoke.
Association between Preoperative and Current
Dyspnea
The distribution of current dyspnea, as reported by the
BDI, is shown in Figure 1. The number of participants
reporting current dyspnea was 205 (60%). Comparing rates of
preoperative (21%) and current dyspnea (60%) revealed a
nearly 3-fold increase (2  33.04, p  0.001). Overall, 133
individuals (39% of total sample) reported current dyspnea
who had not reported dyspnea before their surgery.
Correlates of Dyspnea
Pearson correlations between current dyspnea and po-
tential correlates described previously are shown in Table 3.
The following were significantly associated (p  0.05) with
the presence of dyspnea: older age, being retired or unem-
ployed, having less than a high school education, presence of
preoperative dyspnea, reduced preoperative FEV1%, reduced
preoperative diffusing capacity, presence of pulmonary dis-
ease, any history of tobacco use, any moderate or strenuous
physical activity, and having clinically significant depression
symptoms (HADS depression subscale 8). These variables
were then included in a multivariate logistic regression. As
shown in Table 4, preoperative dyspnea (odds ratio [OR] 
TABLE 1. Demographic Characteristics of Sample (n  342)
Characteristic n %
Age (y) (M  68.9, SD  9.8)
35–54 37 10.8
55–64 70 20.5
65–74 126 36.8
75 109 31.9
Missing (n) (0)
Sex
Male 125 36.5
Female 217 63.5
Missing (n) (0)
Married/partnered
No 130 38.0
Yes 212 62.0
Missing (n) (0)
Employment status
Employed/homemaker 125 36.8
Retired/unemployed 215 63.2
Missing (n) (2)
Race/ethnicity
Non-Hispanic white 317 93.0
Non-Hispanic black 10 2.9
Non-Hispanic Asian/Pacific 4 1.2
Islander
Non-Hispanic other 2 0.6
Hispanic 8 2.3
Missing (n) (1)
Education
High school graduate 109 32.0
At least some college 232 68.0
Missing (n) (1)
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5.31), reduced preoperative diffusion capacity (OR  0.98),
any moderate or strenuous physical activity (OR 0.41), and
having clinically depression symptoms (OR  4.10) were
statistically significant multivariate correlates of current dys-
pnea. The selected indicators explained 32% of the variance
in current dyspnea using an adjusted R2.
DISCUSSION
This study makes several notable contributions to our
understanding of long-term lung cancer survivorship. We
found dyspnea to be highly prevalent, occurring among 60%
of the lung cancer survivors examined, and associated with
the presence of preoperative dyspnea, lower preoperative
diffusing capacity, lack of engagement in any moderate or
strenuous physical activity, and the presence of clinically
significant depression symptoms.
The identification of potentially modifiable risk factors
associated with dyspnea is perhaps the most significant find-
ing. This implies that strategies which improve physical
FIGURE 1. Frequency of self-reported current dyspnea us-
ing the Baseline Dyspnea Index. Of 342 patients, 205 (60%)
reported current dyspnea, defined as a score of 9 or less.
Data are reported on a scale of zero through 12 with lower
scores indicating more severe dyspnea.
TABLE 2. Medical Characteristics of Sample (n  342)
Characteristic n %
Time since surgical resection (M  3.5 y, SD  1.2)
1–2 y 37 10.8
2–3 y 99 28.9
3–4 y 88 25.7
4–5 y 75 21.9
5–6 y 43 12.6
Missing (n) (0)
Type of surgical resection
Wedge 40 11.7
Segmentectomy 30 8.8
Lobectomy 258 75.4
Bilobectomy 8 2.4
Pneumonectomy 6 1.7
Missing (n) (0)
Preoperative dyspnea
No 270 78.9
Yes 72 21.1
Missing (n) (0)
Preoperative FEV1% (M  89.0, SD  20.3)
Severe (50%) 12 3.6
Moderate (50–69%) 48 14.4
Mild (70%) 273 82.0
Missing (n) (9)
Preoperative diffusing capacity % (M  83.7, SD  25.8)
Severe (50%) 17 5.5
Moderate (50–69%) 67 21.6
Mild (70%) 226 72.9
Missing (n) (32)
Video-assisted thoracic surgery (VATS) only
Yes 61 18.0
No 280 82.0
Missing (n) (1)
Preoperative body mass index (BMI) (M  26.8, SD  4.9)
18.5 (underweight) 6 1.7
18.5–24.9 (normal) 133 38.9
25–29.9 (overweight) 125 36.5
30 (obese) 78 22.8
Missing (n) (0)
Cardiac comorbidities
Atrial fibrillation 9 3.4
Angina 2 0.8
Coronary artery bypass graft 10 3.8
Hypertension 74 28.0
Myocardial infarction 11 4.2
Coronary angioplasty 4 1.5
Valvular condition 2 0.8
None 159 57.6
Missing (n) (78)
Pulmonary comorbidities
Asthma 21 6.2
COPD 79 23.1
Tuberculosis 1 0.3
Characteristic n %
None 240 70.4
Missing (n) (1)
Current smoking status
Current smoker 19 5.5
Former smoker 268 78.4
Never smoker 55 16.1
Missing (n) (0)
Moderate or strenuous physical activity
Any moderate/strenuous 164 47.9
None 178 52.1
Missing (n) (0)
Psychological distress
HADS depression (8) 32 9.4
HADS anxiety (8) 69 20.2
Missing (n) (0)
BDI, Baseline Dyspnea Index; HADS, Hospital Anxiety and Depression Scale.
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activity or relieve depressive symptoms may result in im-
proved breathlessness. An association between physical ac-
tivity and improved clinical outcomes has been shown pre-
viously for a number of lung diseases, including COPD.21
Several studies also imply that improving physical activity is
beneficial in the period immediately after lung cancer resec-
tion.22–23 In a study by Cesario et al.,22 mean 6-minute walk
distance increased by nearly 100 m compared with the pre-
operative baseline among patients attending inpatient pulmo-
nary rehabilitation after surgery. In a survey of patients
surviving at least 5 years after lung cancer resection, those
engaging in regular physical activity reported a better overall
quality of life than those who did not.23
Data presented in this study suggest that the need for
physical activity may extend beyond the immediate postop-
erative period. In addition, the high prevalence of dyspnea
and the fact that fewer than half of patients reported pursuing
any moderate/strenuous physical activity at all implies that a
significant subset of lung cancer survivors exists who may
potentially benefit from strategies that increase activity at
suitable time points.
Depression symptoms were not very prevalent in this
sample, occurring among about 10% of lung cancer survi-
vors, but were nonetheless strongly associated with dyspnea.
The question of whether treating depression relieves dyspnea
among lung cancer patients has not been specifically ad-
dressed; however, there exists a limited literature regarding
treating depression in other lung diseases. Patients with both
depression and COPD who took nortriptyline reported less
dyspnea performing low-demand physical activities, such as
brushing teeth and combing hair, than those receiving placebo.24
Eiser et al.25 reported that patients with COPD and depression
who took paroxetine, a serotonin reuptake inhibitor, for 3
months had improved depression and dyspnea scores, as well
as exercise tolerance.
Although the association in this study between depres-
sion and dyspnea was independent of moderate/strenuous
physical activity, evidence suggests that without treating
depression symptoms, when present, lung cancer survivors
will not adhere to advice and interventions designed to
improve physical activity.26 Therefore, efforts to identify
lung cancer survivors who have depressive symptomatology
and to provide these patients additional psychosocial support
could potentially mitigate depression as a barrier for post-
treatment rehabilitation efforts.
Our results are similar to the only other study of
long-term pulmonary impairment among lung cancer survi-
vors receiving surgical resection. Sarna et al.8 examined
respiratory symptoms among patients 5 or more years after
surgery. Among 142 patients, they found dyspnea occurring
among 63% of patients; 15% were so dyspneic that they
could not leave their homes or dress themselves. Correlates of
dyspnea included male gender, current smoking, bronchodi-
lator use, exposure to second hand smoke, and more medical
comorbidities. Depression was not examined. The lack of
consistency in correlates of dyspnea between our sample and
the sample of Sarna et al. may be explained by several
demographic differences. Patients in the later study had
longer duration time since surgery, poorer preoperative lung
function as determined by FEV1, and were less likely to
undergo pneumonectomy. Nevertheless, the similar finding
that roughly 60% of long-term lung cancer survivors experi-
ence dyspnea underscores the clinical importance of this
symptom for long-term management.
Strengths of our study include a good patient response
rate (65%) and no indication of demographic differences
between participants and decliners. Data on dyspnea and
depression were assessed with well-validated measures. The
size of the cohort, more than 340 patients, is larger than most
reports of lung cancer survivorship.
TABLE 3. Bivariate Correlations Between Current Dyspnea
and Selected Demographic and Medical Variables
Characteristic r p
Age 0.13 0.01
Sex (male) 0.04 0.50
Employed (v. retired/unemployed) 0.22 0.01
Greater than high school education 0.15 0.01
Years since surgical resection 0.05 0.35
Type of resectiona
Lobectomy 0.05 0.31
Bilobectomy/pneumonectomy 0.10 0.06
Preoperative dyspnea 0.31 0.01
Preoperative FEV1% 0.26 0.01
Preoperative diffusing capacity % 0.30 0.01
Video-assisted thoracic surgery (VATS) only 0.01 0.88
Preoperative body mass index 0.05 0.32
Presence of cardiac disease 0.05 0.40
Presence of pulmonary disease 0.12 0.02
History of tobacco use 0.14 0.01
Any moderate/strenuous physical activity (currently) 0.29 0.01
Clinically significant symptoms of depression (HADS 8) 0.18 0.01
Clinically significant symptoms of anxiety (HADS 8) 0.02 0.65
a Type of lung resection as compared with segmentectomy/wedge resection.
HADS, Hospital Anxiety and Depression Scale.
TABLE 4. Multivariate Correlates of Current Dyspnea
(n  304, adj R2  0.32)
Characteristic Odds Ratio (95% CI) p
Age 10.2 (0.99–1.05) 0.24
Employed (v. retired/unemployed) 0.63 (0.34–1.16) 0.14
Greater than high school education 0.93 (0.51–1.70) 0.82
Preoperative dyspnea 5.31 (2.26–12.51) 0.01
Preoperative FEV1% 0.99 (0.97–1.01) 0.41
Preoperative diffusing capacity % 0.98 (0.97–0.99) 0.01
Presence of pulmonary disease 0.76 (0.39–1.47) 0.41
History of tobacco use 1.46 (0.67–3.18) 0.34
Any moderate/strenuous physical
activity (currently)
0.41 (0.24–0.71) 0.01
Clinically significant symptoms of
depression (HADS 8)
4.10 (1.01–16.55) 0.05
CI, confidence interval; HADS, Hospital Anxiety and Depression Scale.
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Several limitations to the study should also be noted.
Measurements of preoperative dyspnea were derived from
routine clinical observations and documentation in the med-
ical record, raising potential concerns about under-reporting
of preoperative dyspnea. Further, study participants were less
likely to have reported preoperative dyspnea than study
decliners, raising the possibility that this study may underes-
timate the prevalence of current dyspnea among survivors of
early-stage NSCLC. The study participants were early stage,
relatively well educated, predominantly non-Hispanic white,
and followed at a single institution; the findings may not
generalize beyond these sample characteristics. Similarly,
most patients had lobectomy, limiting inferences based on the
amount of lung tissue resected. A small number of patients in
this cohort received chemotherapy and radiation. It remains to be
determined how adjuvant chemoradiation and targeted molecu-
lar-based chemotherapy may affect the spectrum of long-term
complications experienced by lung cancer survivors. The cross-
sectional design precludes making any causal inferences regard-
ing direction of associations detected. It is possible, for instance,
that some patients may engage in less moderate or strenuous
activity because they experience more dyspnea. A prospective
trial would be necessary to prove that increased activity actually
attenuates dyspnea postoperatively.
Finally, any enthusiasm regarding the potential for
improved physical activity to relieve dyspnea among lung
cancer patients may be tempered by the historical low adher-
ence rates to exercise after pulmonary and cardiac rehabili-
tation programs. Consequently, future research in this area
should not only address whether improved physical activity is
helpful, but also to what degree any perceived benefit can be
sustained.
CONCLUSION
Previous reports of NSCLC survivors have generally
been limited to the short-term period after surgery. This study
is among the first to quantify the presence and correlates of
dyspnea among the growing number of long-term lung cancer
survivors. Dyspnea is indeed highly prevalent and may per-
sist long after the immediate treatment period. These findings
also suggest that modifiable risk factors for dyspnea may exist.
Future research is needed to test whether screening and inter-
vening for depression and physical inactivity among lung cancer
survivors has beneficial effects with regards to dyspnea.
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